Assoc. Prof. Ali Eser received his medical education at Uludağ University Faculty of Medicine; He completed his internal medicine residency training at Istanbul Training and Research Hospital and his hematology residency training at Marmara University.
Afterward, he completed his compulsory service at Marmara University Hematology Clinic, firstly at Çanakkale University and then at Bezmialem Vakıf University. He served as a lecturer. After working as a hematology specialist and assistant physician in charge of the adult bone marrow transplant unit for 2 years at Hisar Intercontinental Hospital, he worked as a lecturer at Bezmialem Vakıf University and in the adult bone marrow transplant unit at Istanbul Yeniyüzyıl University, and finally for 1 year. He worked as the responsible physician of the adult bone marrow transplant unit at Liv Hospital Gaziantep Hospital for some time. He received the title of associate professor in March 2022.
Mehr lesenAssoc. Prof. Ali Eser received his medical education at Uludağ University Faculty of Medicine; He completed his internal medicine residency training at Istanbul Training and Research Hospital and his hematology residency training at Marmara University.
Afterward, he completed his compulsory service at Marmara University Hematology Clinic, firstly at Çanakkale University and then at Bezmialem Vakıf University. He served as a lecturer. After working as a hematology specialist and assistant physician in charge of the adult bone marrow transplant unit for 2 years at Hisar Intercontinental Hospital, he worked as a lecturer at Bezmialem Vakıf University and in the adult bone marrow transplant unit at Istanbul Yeniyüzyıl University, and finally for 1 year. He worked as the responsible physician of the adult bone marrow transplant unit at Liv Hospital Gaziantep Hospital for some time. He received the title of associate professor in March 2022.
Dr. Toluy Özgümüş has graduated from Istanbul University, Cerrahpaşa Faculty of Medicine in 2008 and completed his internal medicine specialty training at Haydarpaşa Numune Training and Research Hospital between 2009 and 2013. He received his Hematology subspecialty training at Marmara University Hematology Department between 2014-2017; He performed his compulsory service at Kars Harakani State Hospital between 2017-2019. He worked at Sancaktepe Şehit Prof. Dr. Ilhan Varak Training and Research Hospital between 2019-2023.
He is experienced in the field of bleeding and coagulation disorders, especially coagulation disorders (thrombophilia), and has dealt with the diagnosis and treatment of more than 1000 patients. Since he worked in the pandemic hospital of the Anatolian side of Istanbul during the pandemic period, he has extensive experience in the hematological findings of Covid-19 infection and the management of Covid-19 infection in hematological diseases. Hundreds of patient experiences are available in the diagnosis of myeloproliferative diseases such as Polycythemia Vera and Essential Thrombocytosis, in their differentiation from blood cell elevations due to other frequently confused causes, and in their treatment. He has experience in the diagnosis and all treatment processes of rare hematological cancers such as multiple myeloma, acute and chronic leukemias, lymphomas and histiocytosis, as well as bone marrow transplantation.
MEDICAL INTERESTS
Clotting Disorders (Thrombophilia)
Bleeding Disorders
Myeloproliferative Diseases
Anemias (Anemia)
Acute and Chronic Leukemias
lymphomas
Bone marrow transplantation
Mehr lesenDr. Toluy Özgümüş has graduated from Istanbul University, Cerrahpaşa Faculty of Medicine in 2008 and completed his internal medicine specialty training at Haydarpaşa Numune Training and Research Hospital between 2009 and 2013. He received his Hematology subspecialty training at Marmara University Hematology Department between 2014-2017; He performed his compulsory service at Kars Harakani State Hospital between 2017-2019. He worked at Sancaktepe Şehit Prof. Dr. Ilhan Varak Training and Research Hospital between 2019-2023.
He is experienced in the field of bleeding and coagulation disorders, especially coagulation disorders (thrombophilia), and has dealt with the diagnosis and treatment of more than 1000 patients. Since he worked in the pandemic hospital of the Anatolian side of Istanbul during the pandemic period, he has extensive experience in the hematological findings of Covid-19 infection and the management of Covid-19 infection in hematological diseases. Hundreds of patient experiences are available in the diagnosis of myeloproliferative diseases such as Polycythemia Vera and Essential Thrombocytosis, in their differentiation from blood cell elevations due to other frequently confused causes, and in their treatment. He has experience in the diagnosis and all treatment processes of rare hematological cancers such as multiple myeloma, acute and chronic leukemias, lymphomas and histiocytosis, as well as bone marrow transplantation.
MEDICAL INTERESTS
Clotting Disorders (Thrombophilia)
Bleeding Disorders
Myeloproliferative Diseases
Anemias (Anemia)
Acute and Chronic Leukemias
lymphomas
Bone marrow transplantation
Assoc. Prof. Dr. Oğuzhan BABACAN completed his undergraduate, specialty and sub-specialty education at GATA Military Medical Faculty/Ankara. After becoming a specialist in Pediatrics, he worked in the field of Social Pediatrics for two years, where Healthy Baby Monitoring and vaccine follow-up were carried out. Then, she completed her subspecialty training in Pediatric Hematology and Oncology and continued her studies in the field of pediatric blood and cancer diseases. In addition to the treatment of children suffering from leukemia, lymphoma, solid tumors and other blood diseases, she has been working in the Bone Marrow Transplantation (Transplant) Unit for 13 years in Allogeneic (unrelated and intrafamilial), Autologous (from the patient himself) and Haploidentical (partially HLA compatible) hematopoietic stem cell transplantation. In 2018, he received the title of Associate Professor in the field of Pediatric Hematology and Oncology Science/Art.
MEDICAL AREAS OF INTEREST
Healthy baby follow-up and vaccinations
Lymph node enlargement
Pediatric patients with anemia (anemia)
Leukemia
Lymphoma
Bone Marrow Transplant
ITP
Thalassemias
Hemophiliacs
Solid tumors
Hemangioma
Childhood blood disorders
Children with frequent infections
Fever of unknown origin
Malnutrition in children
Mehr lesenAssoc. Prof. Dr. Oğuzhan BABACAN completed his undergraduate, specialty and sub-specialty education at GATA Military Medical Faculty/Ankara. After becoming a specialist in Pediatrics, he worked in the field of Social Pediatrics for two years, where Healthy Baby Monitoring and vaccine follow-up were carried out. Then, she completed her subspecialty training in Pediatric Hematology and Oncology and continued her studies in the field of pediatric blood and cancer diseases. In addition to the treatment of children suffering from leukemia, lymphoma, solid tumors and other blood diseases, she has been working in the Bone Marrow Transplantation (Transplant) Unit for 13 years in Allogeneic (unrelated and intrafamilial), Autologous (from the patient himself) and Haploidentical (partially HLA compatible) hematopoietic stem cell transplantation. In 2018, he received the title of Associate Professor in the field of Pediatric Hematology and Oncology Science/Art.
MEDICAL AREAS OF INTEREST
Healthy baby follow-up and vaccinations
Lymph node enlargement
Pediatric patients with anemia (anemia)
Leukemia
Lymphoma
Bone Marrow Transplant
ITP
Thalassemias
Hemophiliacs
Solid tumors
Hemangioma
Childhood blood disorders
Children with frequent infections
Fever of unknown origin
Malnutrition in children
Einer der besten Krebsspezialisten in Europa, Pädagoge und Krebsforscher, Präsident der Central European Cooperative Oncology Group (CECOG).
Hat über 600 wissenschaftliche Arbeiten zur Krebsbehandlung veröffentlicht.
Einer der besten Krebsspezialisten in Europa, Pädagoge und Krebsforscher, Präsident der Central European Cooperative Oncology Group (CECOG).
Hat über 600 wissenschaftliche Arbeiten zur Krebsbehandlung veröffentlicht.
1- SSI Tepecik Hospital Pediatric Oncology Clinic (1990)
2- SSI Tepecik Hospital Pediatric Bone Marrow Transplantation Unit (1992)
3- EU Faculty of Medicine Pediatric Bone Marrow Transplantation Unit (1998)
4- FOUNDER of JOURNAL OF PEDIATRIC RESEARCH, 2014; SCI application was made in 2022.
1. İzmir BUÇH EAH Pediatric Bone Marrow Transplantation Unit (2019)
2. Ümraniye EAH Pediatric Bone Marrow Transplantation Unit (2020)
3. Kanuni Sultan Süleyman EAH Pediatric Bone Marrow Transplantation Unit (2020) (Transferred to Çam Sakura EAH)
Kansoy S. "Bone Marrow and Stem Cell Transplantation Child Health and Diseases, 1st edition, EU Faculty of Medicine Printing House, 1999, İzmir
Kansoy S. Bone marrow transplantation in Thalassemia Major III. Aegean Thalassemia Days Book, 2000, Izmir
Kansoy S. Pediatric KIT Center Standards in Turkey. Childhood Acute Leukemias, Antalya 2000: 73-5
Kansoy S. Late Side Effects in Children. Special issue of Bone Marrow Transplantation Journal of Turkish Clinics. 2003
Kansoy S. Stem Cell Applications in Bone Marrow and Stem Cell Transplantation. Pediatric Oncology Nursing Course Book, İzmir, 2005
Kansoy S. Cord Blood as a Stem Cell Source. Stem Cell Special Issue. Turkey Clinics, 2008
Kansoy S. Stem Cell Transplantation in Lymphomas. General Pediatrics Book, Ed. Prof.Dr.Enver Hasanoglu, 2009
Kansoy S, Aksoylar S. Bone Marrow Transplantation in Children. Pediatrics, 2014 and 2017
Kansoy S. Rhabdomyosarcoma. Pediatrics, 2014 and 2017
Kansoy S. Approach to the child with cancer according to clinical findings. Pediatrics, 2014 and 2017
11. Çetingül N, S.Kansoy, M.Kantar. Oncological Diseases. Pediatrics (Ed. A. Cura), 641-672, Ege University Print house, İzmir, 1999. (1.05 points)
Kansoy S, M.Kantar. Head, Face and Eye Examination. Pediatric Prosthetic Physical Examination and Symptom Information (Ed. A.Cura)
Kantar M. Metabolic Emergency Problems in Oncology. Oncologic Emergencies and Supportive Care in Childhood (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003.
Cord Blood Transplants in Turkey. HEMATOLOGIST, 2016
Kansoy S. Central Nervous System Tumors in Children Pediatrics, 2014 and 2017
Acute myeloblastic leukemia in children and its treatment. Pediatric Oncology Textbook, Poplack's Turkish, 2020
National pediatric stem cell transplant activity, 2020
Childhood stem cell transplantation indications, Turkey Clinics - International book 2020
In addition to the studies and papers in international journals published in large numbers, he is involved in international multicenter studies in some journals with high impact value.
Mehr lesen1- SSI Tepecik Hospital Pediatric Oncology Clinic (1990)
2- SSI Tepecik Hospital Pediatric Bone Marrow Transplantation Unit (1992)
3- EU Faculty of Medicine Pediatric Bone Marrow Transplantation Unit (1998)
4- FOUNDER of JOURNAL OF PEDIATRIC RESEARCH, 2014; SCI application was made in 2022.
1. İzmir BUÇH EAH Pediatric Bone Marrow Transplantation Unit (2019)
2. Ümraniye EAH Pediatric Bone Marrow Transplantation Unit (2020)
3. Kanuni Sultan Süleyman EAH Pediatric Bone Marrow Transplantation Unit (2020) (Transferred to Çam Sakura EAH)
Kansoy S. "Bone Marrow and Stem Cell Transplantation Child Health and Diseases, 1st edition, EU Faculty of Medicine Printing House, 1999, İzmir
Kansoy S. Bone marrow transplantation in Thalassemia Major III. Aegean Thalassemia Days Book, 2000, Izmir
Kansoy S. Pediatric KIT Center Standards in Turkey. Childhood Acute Leukemias, Antalya 2000: 73-5
Kansoy S. Late Side Effects in Children. Special issue of Bone Marrow Transplantation Journal of Turkish Clinics. 2003
Kansoy S. Stem Cell Applications in Bone Marrow and Stem Cell Transplantation. Pediatric Oncology Nursing Course Book, İzmir, 2005
Kansoy S. Cord Blood as a Stem Cell Source. Stem Cell Special Issue. Turkey Clinics, 2008
Kansoy S. Stem Cell Transplantation in Lymphomas. General Pediatrics Book, Ed. Prof.Dr.Enver Hasanoglu, 2009
Kansoy S, Aksoylar S. Bone Marrow Transplantation in Children. Pediatrics, 2014 and 2017
Kansoy S. Rhabdomyosarcoma. Pediatrics, 2014 and 2017
Kansoy S. Approach to the child with cancer according to clinical findings. Pediatrics, 2014 and 2017
11. Çetingül N, S.Kansoy, M.Kantar. Oncological Diseases. Pediatrics (Ed. A. Cura), 641-672, Ege University Print house, İzmir, 1999. (1.05 points)
Kansoy S, M.Kantar. Head, Face and Eye Examination. Pediatric Prosthetic Physical Examination and Symptom Information (Ed. A.Cura)
Kantar M. Metabolic Emergency Problems in Oncology. Oncologic Emergencies and Supportive Care in Childhood (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003.
Cord Blood Transplants in Turkey. HEMATOLOGIST, 2016
Kansoy S. Central Nervous System Tumors in Children Pediatrics, 2014 and 2017
Acute myeloblastic leukemia in children and its treatment. Pediatric Oncology Textbook, Poplack's Turkish, 2020
National pediatric stem cell transplant activity, 2020
Childhood stem cell transplantation indications, Turkey Clinics - International book 2020
In addition to the studies and papers in international journals published in large numbers, he is involved in international multicenter studies in some journals with high impact value.
Dr. Dror Levin ist leitender Kinderarzt und Direktor der Behandlungsabteilungen für Blutkrankheiten und Knochenkrebs (Sarkom) im Kinderkrankenhaus „Dana“ bzw. im medizinischen Zentrum „Sourasky“. Er ist Facharzt für Kindermedizin, Hämatologie und Onkologie und hat zusätzliche Auslandserfahrung am Orthopädischen Institut Rizzoli in Italien.
Mehr lesenDr. Dror Levin ist leitender Kinderarzt und Direktor der Behandlungsabteilungen für Blutkrankheiten und Knochenkrebs (Sarkom) im Kinderkrankenhaus „Dana“ bzw. im medizinischen Zentrum „Sourasky“. Er ist Facharzt für Kindermedizin, Hämatologie und Onkologie und hat zusätzliche Auslandserfahrung am Orthopädischen Institut Rizzoli in Italien.
Bildung
Medizinische Fakultät: Ben-Gurion-Universität
Spezialisierung
Anerkannte Erfahrung
Innere Medizin und Hämatologie
Zusätzliche Ausbildung
NHLBI/NIH, Bethesda, USA
Klinische Erfahrung
Akademische Erfahrung
Fachpublikationen
Über 80 Fachpublikationen
Gemeinschaftsmitgliedsschaft
Interessensgebiete und Aktivitäten
Behandlung und Forschung bei CLL
Mehr lesenBildung
Medizinische Fakultät: Ben-Gurion-Universität
Spezialisierung
Anerkannte Erfahrung
Innere Medizin und Hämatologie
Zusätzliche Ausbildung
NHLBI/NIH, Bethesda, USA
Klinische Erfahrung
Akademische Erfahrung
Fachpublikationen
Über 80 Fachpublikationen
Gemeinschaftsmitgliedsschaft
Interessensgebiete und Aktivitäten
Behandlung und Forschung bei CLL
Undergraduate and Doctoral Education:
* 1992-1999 Ondokuz Mayıs University Faculty of Medicine
* 2002-2007 Inonu University, Faculty of Medicine, Child Health and Diseases,
Pediatrics Residency
* 2015-2018 Inonu University, Faculty of Medicine, Pediatrics, Pediatric
Hematology and Oncology Subspecialization
*2017-Ankara University, Pediatrics, Oncology minor residency (8 months)
Mehr lesenUndergraduate and Doctoral Education:
* 1992-1999 Ondokuz Mayıs University Faculty of Medicine
* 2002-2007 Inonu University, Faculty of Medicine, Child Health and Diseases,
Pediatrics Residency
* 2015-2018 Inonu University, Faculty of Medicine, Pediatrics, Pediatric
Hematology and Oncology Subspecialization
*2017-Ankara University, Pediatrics, Oncology minor residency (8 months)
Professor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.
He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977.
In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa.
Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University.
Current Positions:
In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009).
Publications: santoro%a - Search Results - PubMed (nih.gov)
Mehr lesenProfessor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.
He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977.
In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa.
Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University.
Current Positions:
In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009).
Publications: santoro%a - Search Results - PubMed (nih.gov)